Abstract
T regulator lymphocytes (Tregs) play a key role in the maintenance of immune tolerance and in the development of autoimmune diseases. Expression of Foxp3 is specific for Tregs, and can be used for the identification of these cells. This study investigated the variations of Tregs Foxp3+ in the kidney biopsies inflammatory infiltrate of different lupus nephritis classes compared to that of ANCA glomerulonephritis, acute tubulointerstitial nephritis and nephroangiosclerosis. Sections of paraffin-embedded tissue have been stained by immunohistochemistry with anti-CD3 and anti-FoxP3 antibodies. We find that the ratio of FoxP3+/CD3+ cells is significantly lower in patients with lupus nephritis class IV and in patients with vasculitides than in the course of nephroangiosclerosis, tubulointerstitial nephritis and lupus nephritis class V. The data presented herein demonstrate a decrease of FoxP3+ Treg cells in the inflammatory infiltrate of lupus nephritis, particularly during the most active phases of lupus nephritis, as observed in the course of a IV class nephritis.
Similar content being viewed by others
References
Manzi S (2009) Lupus update. Clevel Clin J Med 76(2):137–142
Ippolito A, Petri M (2008) An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 26(5):S72–S79
Sarzi-Puttini P, Atzeni F, Iaccarino L et al (2005) Environment and systemic lupus erythematosus: an overview. Autoimmunity 38(7):465–472
Gigante A, Gasperini ML, Afeltra A et al (2011) Cytokines expression in SLE nephritis. Eur Rev Med Pharmacol Sci 15(1):15–24
Mason LJ, Isenberg D (2005) The pathogenesis of systemic lupus erythematosus. In: Davidson AM, Cameron JS, Grunfeld JP et al (eds) Oxford textbook of clinical nephrology. Oxford University Press, Oxford, England, pp 809-829
Markopoulou A, Kyttaris VC (2013) Small molecules in the treatment of systemic lupus erythematosus. Clin Immunol 148(3):359–368
Savino MT, Ulivieri C, Emmi G et al (2013) The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. J Leukoc Biol 93(4):549–559
Wing K, Sakaguchi S (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11(1):7–13
Weaver CT, Hatton RD (2009) Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective. Nat Rev Immunol 9(12):883–889
Torchinsky MB, Blander JM (2010) T helper 17 cells: discovery, function, and physiological trigger. Cell Mol Life Sci 67(9):1407–1421
Bonelli M, Smolen JS, Scheinecker C (2010) Treg and lupus. Ann Rheum Dis 69:65–66
La Cava A (2009) The busy life of regulatory T cells in systemic lupus erythematosus. Discov Med 8(40):13–17
Dummer CD, Carpio VN, Gonçalves LF et al (2012) FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance. Transpl Immunol 26(1):1–10
Li XC, Turka LA (2010) An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 6(10):577–583
Horwitz DA, Zheng SG, Gray JD (2008) Natural and TGF- β-induced Foxp3+ CD4+ CD25+ regulatory T cells are not mirror images of each other. Trends Immunol 29(9):429–435
Zheng SG, Wang J, Horwitz AD (2008) Cutting edge) Foxp3+ CD4+ CD25+ regulatory Tcells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6. Journal of Immunology 180(11):7112–7116
Kaplan JM, Woodworth L, Smith K et al (2008) Therapeutic benefit of treatment with anti- thymocyte globulin and latent TGF-β1 in the MRL/lpr lupus mouse model. Lupus 17(9):822–831
Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241–250
Hochberg MC (1997) Updating the American College of Rheumatism revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 40:17–25
Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of SLEDAI: a disease activity index for lupus patients. Arthr Rheum 35:630–640
Hahn BH, Karpouza GA, Tsao BP (2005) Pathogenesis of systemic lupus erythematosus. In: Harris ED (ed) Kelley’s textbook of rheumatology, 7th edn. WB Saunders, Philadelphia, pp 1174–1200
Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358(9):929–939
Shevach EM (2011) Biological functions of regulatory T cells. Adv Immunol 112:137–176
Takakubo Y, Konttinen YT (2012) Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases. Clin Dev Immunol 2012:941346. doi:10.1155/2012/941346
Tucci M, Stucci S, Strippoli S et al (2010) Cytokine overproduction, T-cell activation, and defective t-regulatory functions promote nephritis in systemic lupus erythematosus. J Biomed Biotechnol 2010:457146. doi:10.1155/2010/457146
Grande JP, Balow JE (1998) Renal biopsy in lupus nephritis. Lupus 7(9):611–615
Wang P, Zheng SG (2013) Regulatory T cells and B cells, implication on autoimmune diseases Int J. Clin Exp Pathol 6:2668–2674
Xing Q, Wang B, Su H et al (2012) Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int 32:949–958
Conflict of interest
None.
Statement of human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the author.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Afeltra, A., Gigante, A., Margiotta, D.P.E. et al. The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study. Intern Emerg Med 10, 677–683 (2015). https://doi.org/10.1007/s11739-015-1212-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-015-1212-x